Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level
Barry E. Bleske, John M. Nicklas, Robert L. Bard, Robert D. Brook, Paul A. Gurbel, Kevin P. Bliden, Sanjay Rajagopalan, Bertram Pitt
Dive into the research topics of 'Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level'. Together they form a unique fingerprint.